France's Le Monde enters into content partnership with AI startup Perplexity
May 14 (Reuters) - French newspaper Le Monde entered into a content partnership with U.S.-based artificial intelligence company Perplexity on Wednesday, as AI startups compete for deals with news publications to improve the responses of their products amid intensifying competition.
The deal grants Perplexity access to Le Monde's content to enhance its search engine's responses, while the newspaper will use the Nvidia-backed (NVDA.O), opens new tab startup's technology to develop new AI products.
This partnership will also support publishers whose content is featured in Perplexity's generated answers.
"At Le Monde, we have continued to explore new partnerships with leading AI players to enlarge our audience, expand our development capacities, and to build new sources of revenues," said Louis Dreyfus, Le Monde's CEO.
Perplexity has already secured agreements with over a dozen media partners, including the Los Angeles Times and the Independent, as part of a program that shares a portion of ad revenue with the publishers.
Meanwhile, AI firms have faced lawsuits from media groups and news publishers, who accuse them of unlawfully using content and articles without permission to train AI models.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
16 minutes ago
- Reuters
Novartis' Pluvicto shown to slow prostate cancer in earlier setting
FRANKFURT, June 2 (Reuters) - Novartis (NOVN.S), opens new tab said on Monday that its targeted radiotherapy Pluvicto was shown to slow progression of a certain type of prostate cancer, raising the prospect of treatment in an earlier disease stage for a drug technology that the drugmaker has pioneered. The Swiss drugmaker reported a late-stage trial showed a "clinically meaningful benefit" in progression-free survival with a positive trend in overall survival in patients with metastatic prostate cancer that still responds to standard hormone therapy. Almost all of those patients ultimately progress to a form of cancer that no longer responds to hormone therapy, a setting where Pluvicto is already approved, the company added. "These data suggest using (Pluvicto) in an earlier disease setting," Novartis said, adding that this could address a significant unmet need. Novartis only provided a brief summary of trial results and said details would be presented at a medical conference and that it would likely request regulatory approval for wider use in the second half of the year. Pluvicto is part of a class of drugs that combines cell-killing radioactive particles with molecules that attach themselves to tumours, where Novartis has a leading position. The drug saw first-quarter revenue gain 20% to $371 million.
Reuters
16 minutes ago
- Reuters
British digital bank Monzo's annual profit surges, revenue tops $1.35 billion
June 2 (Reuters) - British digital bank Monzo reported revenue above 1 billion pounds ($1.35 billion) for the first time and a sharp rise in annual pretax profit on Monday, driven by strong growth in personal and business customer numbers. The fintech company, which is reportedly gearing up for an initial public offering, posted a pretax profit of 60.5 million pounds for the year ended March 31, 2025, compared with 13.9 million pounds a year earlier. Fiscal year 2024 marked the company's first profitable year. The mobile app-based bank, launched in 2015, is one of several digital banks that have emerged in Britain to challenge the dominance of HSBC (HSBA.L), opens new tab, Lloyds (LLOY.L), opens new tab, Barclays (BARC.L), opens new tab and NatWest (NWG.L), opens new tab - the country's Big Four. Monzo, which has more than 12 million customers, last year outlined plans to expand into Europe through Ireland and strengthen its presence in the United States. Customer deposits increased 48% to 16.6 billion pounds for the year, the lender said. Monzo has considered listing in either Britain or the United States but has not set a firm timeline or chosen a venue for an IPO, a person familiar with the company's plans told Reuters in March. Sky News reported earlier this month that the lender was preparing to appoint bankers to spearhead its planned stock market floatation. Last October, the British bank was valued at 4.5 billion pounds in an employee share sale to a group of investors, including Singapore's sovereign wealth fund. ($1 = 0.7388 pounds)
Reuters
21 minutes ago
- Reuters
Swiss economic output increases as firms rush to beat US tariffs
ZURICH, June 2 (Reuters) - The Swiss economy grew by 0.8% in the first three months of 2025, the government said on Monday, as companies rushed through exports to avoid looming U.S. tariffs. The quarterly figure, which was adjusted for the impact of sporting events, was an uptick from the revised 0.6% increase in the last three months of 2024. It was better than the flash forecast for a 0.7% increase released earlier this month and also above the long term average for Swiss quarterly GDP growth of 0.4%. The figures included growth in services and a big boost from higher exports as companies sent products to the U.S. to avoid the higher tariffs threatened by President Donald Trump. "In particular, exports to the U.S. rose sharply, pointing to possible front-loading in connection with U.S. trade policy," said the State Secretariat for Economic Affairs (SECO). Swiss exports to the United States increased by 17.4% in the first three months of 2025, compared with the previous three months, much higher than the 3.6% increase in overall exports, according to data from the Swiss customs office. Trump's administration imposed a 31% tariff on Swiss imports in April, although the figure has since been temporarily reduced to 10%.
